Target intelligence / Profile preview

Scorpion venom

Molecular classification
Enzyme, Ion channel modulator, Other
01

Overview

Scorpion venom is a complex biological mixture composed of various proteins, peptides, and small molecules, primarily designed for prey immobilization and defense (StatPearls, 2023). The most pharmacologically significant components are neurotoxins that selectively bind to and modulate the activity of voltage-gated ion channels, particularly sodium, potassium, calcium, and chloride channels (Toxins, 2021). This interaction leads to excessive release of neurotransmitters, resulting in a 'sympathetic storm' or 'cholinergic crisis' depending on the species (NIH, 2022). In a clinical context, the venom is the target of antivenom therapies, such as Centruroides Immune F(ab')2, which utilize purified antibody fragments to sequester toxins from the systemic circulation (FDA, 2011). Beyond its toxicity, scorpion venom serves as a rich source of bioactive molecules for drug discovery, with specific toxins like chlorotoxin being investigated for their potential in treating glioma and other cancers (PubMed, 2020). The venom's complexity poses a challenge for treatment, as different species require specific antivenoms to effectively neutralize the unique toxin profiles present (WHO, 2021).

Other names
Scorpion toxinsScorpion sting venomScorpion venom cocktailScorpion neurotoxins
02

Mechanism of action

Antivenoms (e.g., Anascorp) consist of venom-specific F(ab')2 antibody fragments that bind and neutralize venom toxins, preventing their interaction with voltage-gated ion channels and facilitating their elimination (FDA, 2011; StatPearls, 2023).

03

Biological functions

Signal transductionCell deathOther
04

Disease associations

Cardiovascular diseaseOther
05

Safety considerations

Anaphylactic shockSerum sicknessHypersensitivity reactionsAntivenom-induced pyrogenicity
06

Interacting drugs

Centruroides (Scorpion) Immune F(ab')2 (Anascorp)

3 more in the full profile.

07

Biomarkers

Serum venom antigen levelsBlood glucoseCreatine kinase-MB (CK-MB)Electrocardiogram (ECG) changes

Beyond the preview

Go deeper on Scorpion venom.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scorpion venom.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call